This inventor holds 3 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2008-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2016
Title: Henning Birkedal-Hansen: Innovator in Targeted Therapeutics
Introduction
Henning Birkedal-Hansen is a prominent inventor based in Bethesda, MD (US). He has made significant contributions to the field of targeted therapeutics, particularly in the development of innovative methods for delivering compounds to specific cells.
Latest Patents
Birkedal-Hansen holds 3 patents, with his latest inventions focusing on mutated anthrax toxin protective antigen proteins. These proteins are designed to specifically target cells that contain high amounts of cell-surface metalloproteinases or plasminogen activator receptors. The inventions provide methods for administering compounds that can be cleaved by matrix metalloproteinases or plasminogen activators, allowing for the translocation of lethal factor polypeptides into the targeted cells.
Career Highlights
He is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work has been instrumental in advancing the understanding of targeted drug delivery systems.
Collaborations
Birkedal-Hansen has collaborated with notable colleagues, including Stephen H. Leppla and Shi-Hui Liu, contributing to the advancement of research in his field.
Conclusion
Henning Birkedal-Hansen's innovative work in the development of targeted therapeutics highlights his significant role in the scientific community. His contributions continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile